Pivotal Life Sciences logo

Pivotal Life Sciences

North America, California, United States, San Francisco

Description

Pivotal Life Sciences focuses on building data platforms and applications for life sciences investments.

Investor Profile

Pivotal Life Sciences has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Health Care, Medical, Primary and Urgent Care.

Stage Focus

  • Series B (67%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Health Care
  • Medical
  • Primary And Urgent Care
  • Professional Services
  • Biotechnology
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pivotal Life Sciences frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Claritas Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 1
Vista Credit Partners
North America, Texas, United States, Austin
Co-Investments: 1
OT
Europe, Madrid, Spain, Madrid
Co-Investments: 1
TD
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Pivotal Life Sciences?

Engrail Therapeutics

San Diego, California, United States

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Health CareLife ScienceMedicalPharmaceutical
Series BMar 19, 2024
Amount Raised: $157,000,000
Gracell Biotechnologies

Suzhou, Jiangsu, China

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 7, 2023
Amount Raised: $100,000,000
Aptihealth

Troy, New York, United States

Aptihealth specializes in behavioral health, health plans, primary care, therapy, direct messaging, and medication management services.

Health CareMedicalPrimary and Urgent CareProfessional Services
Series BNov 17, 2021
Amount Raised: $50,000,000